Jennifer L Busch, Thomas M Bridges, Robyn Richie-Jannetta, Brian P Hollett, Sharron H Francis, Jackie D Corbin
Frontiers in bioscience (Scholar edition) 2013 Jan 01Ser-64, an autophosphorylation site in the autoinhibitory subdomain of cGMP-dependent protein kinase type I-alpha (PKGI-alpha), lowers affinity for cGMP and suppresses catalytic activity (1). Using the structure of homologous cAMP-dependent protein kinase as a model, three conserved residues (Gln-401, His-404, Cys-518) in the PKGI-alpha catalytic site are predicted to be juxtaposed to Ser-64 (2). Individual point mutants (Q401A, H404A and C518A) and a double mutant (S64A/H404A) have been generated. cGMP or cAMP affinities (K(a)) of each mutant protein for phosphotransferase activation and allosteric (3H)cGMP-binding affinity (K(D)) of each mutant protein are significantly improved over those of wild-type (WT) PKGI-alpha. However, affinities (K(m)) of the mutant PKGs for peptide substrates or ATP are unaltered. Kinase activity ratio (-GMP/+cGMP) of H404A is greater than that for WT, Q401A, or C518A, and similar to that for S64A and S64A/H404A. These results reveal a unique mechanism whereby catalytic domain residues predicted to be spatially close to Ser-64 of the regulatory domain weaken the intrinsically high affinity of PKGI-alpha for cGMP and provide for autoinhibition of catalytic activity.
Jennifer L Busch, Thomas M Bridges, Robyn Richie-Jannetta, Brian P Hollett, Sharron H Francis, Jackie D Corbin. Catalytic site amino acids of PKGI-alpha influence allosteric cGMP binding. Frontiers in bioscience (Scholar edition). 2013 Jan 01;5(2):650-60
PMID: 23277076
View Full Text